GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,075,000 | 0.0% | 24,690 | 0.0% | 0.06% | +14.0% |
| Q1 2022 | $1,075,000 | -1.3% | 24,690 | 0.0% | 0.06% | -10.9% |
| Q4 2021 | $1,089,000 | +15.5% | 24,690 | 0.0% | 0.06% | +6.7% |
| Q3 2021 | $943,000 | -0.4% | 24,690 | +3.8% | 0.06% | +5.3% |
| Q2 2021 | $947,000 | +10.5% | 23,780 | -1.0% | 0.06% | +7.5% |
| Q1 2021 | $857,000 | -3.1% | 24,020 | 0.0% | 0.05% | -1.9% |
| Q4 2020 | $884,000 | -2.2% | 24,020 | 0.0% | 0.05% | -8.5% |
| Q3 2020 | $904,000 | -7.9% | 24,020 | -0.2% | 0.06% | -16.9% |
| Q2 2020 | $982,000 | -7.3% | 24,080 | -13.8% | 0.07% | -16.5% |
| Q1 2020 | $1,059,000 | -19.3% | 27,940 | 0.0% | 0.08% | +6.2% |
| Q4 2019 | $1,313,000 | +10.2% | 27,940 | 0.0% | 0.08% | +8.1% |
| Q3 2019 | $1,192,000 | +6.6% | 27,940 | 0.0% | 0.07% | +10.4% |
| Q2 2019 | $1,118,000 | -4.3% | 27,940 | 0.0% | 0.07% | -2.9% |
| Q1 2019 | $1,168,000 | -29.1% | 27,940 | -35.2% | 0.07% | -34.9% |
| Q4 2018 | $1,648,000 | -4.1% | 43,135 | +0.8% | 0.11% | +11.6% |
| Q3 2018 | $1,719,000 | -0.3% | 42,785 | 0.0% | 0.10% | -5.0% |
| Q2 2018 | $1,725,000 | -99.9% | 42,785 | -0.5% | 0.10% | +11.1% |
| Q1 2018 | $1,679,424,000 | +9.4% | 42,985 | -0.7% | 0.09% | +13.9% |
| Q4 2017 | $1,535,319,000 | -12.9% | 43,285 | -0.3% | 0.08% | -16.8% |
| Q3 2017 | $1,762,365,000 | -4.9% | 43,408 | +1.0% | 0.10% | -9.5% |
| Q2 2017 | $1,853,513,000 | +0.7% | 42,985 | -1.6% | 0.10% | -2.8% |
| Q1 2017 | $1,841,001,000 | +9.5% | 43,667 | 0.0% | 0.11% | +0.9% |
| Q4 2016 | $1,681,616,000 | -10.3% | 43,667 | +0.4% | 0.11% | -13.0% |
| Q3 2016 | $1,875,508,000 | +0.4% | 43,485 | +0.9% | 0.12% | -4.7% |
| Q2 2016 | $1,867,694,000 | +6.8% | 43,094 | -0.1% | 0.13% | +6.6% |
| Q1 2016 | $1,749,489,000 | +23.3% | 43,144 | +29.9% | 0.12% | +17.5% |
| Q4 2015 | $1,419,182,000 | +16.5% | 33,205 | +4.8% | 0.10% | +24.1% |
| Q3 2015 | $1,217,904,000 | -7.7% | 31,675 | 0.0% | 0.08% | +9.2% |
| Q2 2015 | $1,319,264,000 | -10.5% | 31,675 | -0.8% | 0.08% | -9.5% |
| Q1 2015 | $1,473,800,000 | +3.8% | 31,935 | -3.8% | 0.08% | +1.2% |
| Q4 2014 | $1,419,182,000 | -8.5% | 33,205 | -1.5% | 0.08% | -11.7% |
| Q3 2014 | $1,550,200,000 | -14.9% | 33,722 | -1.0% | 0.09% | -12.1% |
| Q2 2014 | $1,822,171,000 | -5.3% | 34,072 | -5.4% | 0.11% | -10.1% |
| Q1 2014 | $1,924,175,000 | -1.1% | 36,013 | -1.1% | 0.12% | -6.3% |
| Q4 2013 | $1,944,731,000 | -2.7% | 36,425 | -8.6% | 0.13% | -14.2% |
| Q3 2013 | $1,998,773,000 | -2.6% | 39,840 | -3.0% | 0.15% | -9.8% |
| Q2 2013 | $2,051,818,000 | – | 41,061 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |